James Cornwall

James Cornwall, PhD, has a diverse and extensive work experience in the pharmaceutical industry. James currently serves as the Head of Business Development at Launch Therapeutics since 2022 and at Abingworth since 2021. Prior to that, they were the President of US-Asia Pharma Advisory from 2015 onwards. From 2015 to 2021, they held the role of Chief Business Officer at Nuvelution Pharma Inc, where they oversaw the advancement of late-stage clinical assets and facilitated financing and market access. James also briefly worked as the Senior Vice President at Samsung Bioepis in 2015. Before that, they had a long tenure at Quintiles, where they held various roles, including VP of Corporate Development, Senior Partner, and VP of Operations and Business Development, from 1993 to 2015. Their career in the pharmaceutical industry began at Glaxo in 1988, where they held various clinical research positions. James Cornwall brings a wealth of experience and expertise in business development, strategic partnerships, and clinical research to their current role.

James Cornwall PhD received their BSc in Pharmacology from the University of Bristol in 1984. James then went on to complete their PhD in Neuropsychopharmacology at the same university from 1984 to 1988.